Publications by authors named "Kelly Mundy"

Claim this Profile
P
Phase II DORA Study of Olaparib with or without Durvalumab as a Chemotherapy-Free Maintenance Strategy in Platinum-Pretreated Advanced Triple-Negative Breast Cancer.
Tira J Tan, Sarah Sammons, Young-Hyuck Im, Lilin She, Kelly Mundy

Clin Cancer Res· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II trial of the PI3 kinase inhibitor buparlisib (BKM-120) with or without enzalutamide in men with metastatic castration resistant prostate cancer.
Andrew J Armstrong, Susan Halabi, Patrick Healy, Joshi J Alumkal, Carolyn Winters, Kelly Mundy

Eur J Cancer· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase Ib Trial of Cabazitaxel and Tasquinimod in Men With Heavily Pretreated Metastatic Castration Resistant Prostate Cancer (mCRPC): The CATCH Trial.
Andrew J Armstrong, Michael S Humeniuk, Patrick Healy, Russell Szmulewitz, Carolyn Winters, Kelly Mundy

Prostate· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A double-blind, randomized, neoadjuvant study of the tissue effects of POMx pills in men with prostate cancer before radical prostatectomy.
Stephen J Freedland, Michael Carducci, Nils Kroeger, Alan Partin, Jian-Yu Rao, Kelly Mundy

Cancer Prev Res (Phila)· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A pharmacodynamic study of rapamycin in men with intermediate- to high-risk localized prostate cancer.
Andrew J Armstrong, George J Netto, Michelle A Rudek, Susan Halabi, David P Wood, Kelly Mundy

Clin Cancer Res· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis